Some studies show that CBD is useful for treating depression, anxiety, sleep disorders and even problematic cannabis use, as well as for reducing the positive symptoms of schizophrenia, with few or no side effects, such as diarrhea, which decreases over time (17, 1.CBD is commonly used to treat psychiatric symptoms.). However, recent evidence has shown that up to 50% of psychiatric patients who use CBD do not report this to their doctors.3 This highlights the perceived efficacy of CBD by consumers and the potential risks of unregulated, poor-quality CBD. Low-quality CBD products, which may contain THC or with a composition that does not match the descriptions on the labels, are widespread on the market and there is clearly an unmet need for high-quality products and new effective therapies. However, some studies suggest that taking CBD may help alleviate anxiety symptoms, especially for those who suffer from social anxiety.
The research revealed that “prior treatment with CBD significantly reduced anxiety, cognitive decline, and discomfort in their speech performance. This study was carried out on people with social anxiety disorder (SAD), and half of the participants received CBD and the other, a placebo, those who received the placebo reported higher levels of anxiety, discomfort, and alertness. The only CBD drug approved by the FDA for childhood seizures, Dravet and Lennox-Gastaut syndromes, is Epidiolex, which is a synthetic substance with a purity of 98% CBD and less than 0.15% THC. While research on CBD and how it affects PTSD is minimal, one case study found that taking 12 to 37 mg of CBD oil by mouth reduced symptoms of anxiety and sleep disorders in a ten-year-old patient with PTSD.
The director of the National Institute on Drug Abuse has stated that CBD oil is safe and, recently, the FDA approved CBD oil for use in children with epilepsy. CBD is said to help with neurological symptoms and potentially reduce the frequency and severity of seizures; however, a study conducted on people diagnosed with Dravet syndrome (a complex childhood epileptic disorder) found that CBD reduced the frequency of seizures by “50%” in 43% of patients. In addition, the use of CBD carries the risk of the user developing toxic side effects due to other medications they are taking as prescribed, since they could develop higher serum concentrations through the interaction of CBD with several CYP P 450 enzymes. The CBD market is promising, but it takes more than just ingredients to enter the CBD market with confidence.
Although the way CBD works to treat anxiety isn't fully understood, it hasn't stopped millions of people who need symptom relief from using CBD. Especially, the CBD content must be subject to stricter regulations with laboratory monitoring to determine and guarantee a particular dose or content of CBD and to exclude a THC content greater than the 0.3% allowed by law. CBD and other products derived from CBD or cannabis should not be considered dietary supplements, as they contain pharmacologically active ingredients. Studies looking at the clinical effect of CBD on certain psychiatric and medical conditions use pure forms of CBD that had previously been tested for content and concentration, but this is not the form that the general public buys at a convenience store.
Through an exclusive strategic partnership with CBD pioneer, Brains Bioceutical, DSM can help innovators explore the therapeutic potential of CBD as an active pharmaceutical ingredient (API), manufactured at a Medicines and Health Products Regulatory Agency (MHRA) center. Interest in cannabis products and CBD has skyrocketed nationally over the past decade, and the current trend is to legalize marijuana and make CBD available without regulations or strict controls for the general public. So, for the many Americans struggling with social anxiety and anxiety disorders, CBD helps them use a holistic approach to managing anxiety by using CBD's natural interaction with the body. .
